Detalhe da pesquisa
1.
Lapatinib-plus-pegylated liposomal doxorubicin in advanced HER2-positive breast cancer following trastuzumab: a phase II trial.
Anticancer Res
; 35(1): 517-21, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25550597